Lung Cancer Update

by Dr Neil Love
20

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.

More
Recent Episodes
  • EGFR Mutation-Positive NSCLC — Fourth Annual National General Medical Oncology Summit
    Apr 30, 2025 – 52:17
  • Oncology Nursing Edition: Antibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings from the 2025 Annual ONS Congress
    Apr 26, 2025 – 01:33:02
  • First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor
    Apr 10, 2025 – 57:28
  • EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
    Feb 6, 2025 – 01:00:02
  • Cases from the Community: Integrating New Research Findings into Current Practice — Lung Cancer
    Dec 13, 2024 – 48:03
  • Meet The Professor: Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer
    Dec 11, 2024 – 58:47
  • The Implications of Recent Datasets for the Current and Future Management of Lung Cancer — A Review of Information from ESMO Congress 2024 and Other Conferences
    Nov 25, 2024 – 01:00:12
  • Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Lung Cancer
    Nov 15, 2024 – 01:05:42
  • Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Lung Cancer from Recent Major Conferences
    Nov 7, 2024 – 54:40
  • The Implications of Recent Datasets for the Current and Future Management of Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review
    Oct 23, 2024 – 42:46
  • The Implications of Recent Datasets for the Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer
    Oct 16, 2024 – 01:00:08
  • The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with Actionable Targets Beyond EGFR
    Oct 8, 2024 – 58:14
  • The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with EGFR Mutations
    Oct 2, 2024 – 58:19
  • Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors
    Sep 19, 2024 – 59:20
  • Striving for Consensus: Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation
    Sep 12, 2024 – 02:03:23
  • Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer
    Aug 21, 2024 – 01:01:24
  • Oncology Today with Dr Neil Love: Novel Agents and Strategies in Lung Cancer
    Aug 14, 2024 – 01:01:43
  • Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer
    Aug 5, 2024 – 01:00:53
  • Oncology Today with Dr Neil Love: An interview with Jonathan W Goldman, MD — Management of Non-Small Cell Lung Cancer with an EGFR Mutation
    Jul 25, 2024 – 47:35
  • Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer
    Jun 12, 2024 – 01:00:48
  • Oncology Today with Dr Neil Love: The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates
    Apr 4, 2024 – 01:14:03
  • Oncology Today with Dr Neil Love: Promising Therapeutic Strategies for Patients with Progressive Metastatic Non-Small Cell Lung Cancer
    Mar 20, 2024 – 01:02:58
  • Implications of Recent Data Sets for the Current and Future Management of Lung Cancer
    Dec 11, 2023 – 01:30:17
  • Inside the Issue: Integrating Targeted and Immunotherapy into the Management of Localized Non-Small Cell Lung Cancer
    Oct 16, 2023 – 01:01:40
  • Striving for Consensus: Current and Future Management of Metastatic Non-Small Cell Lung Cancer in Patients Who Experience Disease Progression on Immune Checkpoint Inhibitor Therapy
    Sep 8, 2023 – 02:43:37
  • Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Lung Cancer from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
    Aug 22, 2023 – 32:16
  • Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer
    May 1, 2023 – 01:03:20
  • Recent Advances and Future Directions in Lung Cancer — With Dr Ibiayi Dagogo-Jack and Stephen Liu (Proceedings from a Symposium in Partnership with NCOA and SCOS)
    Mar 17, 2023 – 59:05
  • Striving for Consensus on the Management of ALK-Positive Lung Cancer
    Mar 6, 2023 – 02:29:53
  • Oncology Today with Dr Neil Love: Management of HER2-Altered Non-Small Cell Lung Cancer?
    Feb 21, 2023 – 01:20:06
  • Oncology Today with Dr Neil Love: Management of Metastatic Non-Small Cell Lung Cancer without an Actionable Mutation
    Feb 13, 2023 – 49:37
  • Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer
    Jan 24, 2023 – 01:00:16
Recent Reviews
  • MG2MD
    Medicine resident subscriber
    Third year medicine resident applying to Heme onc fellowship. I am interested in lung cancer and this podcast inspires critical thinking about patient management and provokes thought about the lung cancer literature. Uniquely has fantastic interviews with experts in the field. A great listen. I recommend this to anyone interested in oncology and interested in improving their knowledge of lung cancer management.
Disclaimer: The podcast and artwork on this page are property of the podcast owner, and not endorsed by UP.audio.